Regen BioPharma sells $125K promissory note to Coventry Enterprises
Regen BioPharma entered into a securities purchase agreement with Coventry Enterprises, LLC, for a $125,000 promissory note convertible to common stock, exempt from registration under Regulation D.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed